Your session is about to expire
← Back to Search
Behavioural Intervention
Virtual Rehabilitation for Spinal Fracture (VIVA Trial)
N/A
Waitlist Available
Led By Lora Giangregorio, PhD
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have had at least one vertebral fracture in the past two years confirmed by a radiology report
Be older than 18 years old
Must not have
Have cauda equina syndrome or spinal cord injury
Had a traumatic fracture (i.e., car accident), an active infection, active inflammatory arthritis with a flare up within the past two years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over the 5-month recruitment period
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to create a virtual rehabilitation program called VIVA for people with spine fractures. Spine fractures are common and can cause long-lasting pain, affecting daily activities. Access to rehabilitation is limited,
Who is the study for?
This trial is for individuals with spinal fractures, often related to osteoporosis. It's designed to help those who struggle with pain and mobility issues due to their fractures. The study aims at people who find it difficult to access rehabilitation services, possibly because they live in rural or remote areas.
What is being tested?
The VIVA program, a virtual rehabilitation toolkit developed for spine fracture patients, is being tested. This pilot study will assess the feasibility of implementing VIVA across three provinces before expanding it further.
What are the potential side effects?
Since this intervention involves a non-invasive virtual rehabilitation program rather than medication or surgery, traditional side effects are not expected. However, participants may experience discomfort or fatigue from new exercises.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had a spine fracture in the last 2 years, confirmed by an X-ray report.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have cauda equina syndrome or a spinal cord injury.
Select...
I had a major injury, an infection, or arthritis flare-up in the last 2 years.
Select...
I cannot follow simple commands or understand instructions without someone to help me.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ over the 5-month recruitment period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over the 5-month recruitment period
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adherence
Recruitment
Retention
Secondary study objectives
Adoption
Balance
Falls
+12 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Wait-list control and delayed receipt groupExperimental Treatment1 Intervention
Participants in this group will continue with their usual care for the first 10 weeks of the study. At week 10, they will receive the same VIVA intervention.
Group II: Immediate receipt groupExperimental Treatment1 Intervention
Participants in this group will receive the VIVA intervention in the first 8 weeks of the study. After the 8-week period, participants will be asked to practice behaviour change techniques for the next 10 weeks.
Find a Location
Who is running the clinical trial?
Hamilton Health Sciences CorporationOTHER
377 Previous Clinical Trials
340,368 Total Patients Enrolled
2 Trials studying Osteoporosis
6,840 Patients Enrolled for Osteoporosis
Unity HealthOTHER
4 Previous Clinical Trials
22,886 Total Patients Enrolled
Arthritis Research Centre of CanadaOTHER
14 Previous Clinical Trials
13,818 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger